HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Capecitabine use in geriatric oncology: an analysis of current safety, efficacy, and quality of life data.

Abstract
Breast and colon cancer occur primarily in people over the age of 65 years, yet standards of care are mostly derived from clinical trials conducted with predominantly younger patients. Clinicians caring for older patients largely rely on clinical judgment and anecdotal experience and most would agree that additional research is needed to optimize care for this growing subset of patients. Capecitabine, a fluoropyrimidine formulated for oral administration has theoretical appeal in this population. In this analysis of published reports and recent presentations published in abstract form, the data on capecitabine efficacy and toxicity are reviewed in the context of patient age. For both breast and colon cancer, capecitabine alone or in combination with other cytotoxics is safe and effective.
AuthorsWilliam B Ershler
JournalCritical reviews in oncology/hematology (Crit Rev Oncol Hematol) Vol. 58 Issue 1 Pg. 68-78 (Apr 2006) ISSN: 1040-8428 [Print] Netherlands
PMID16473520 (Publication Type: Journal Article, Review)
Chemical References
  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil
Topics
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Breast Neoplasms (drug therapy)
  • Capecitabine
  • Clinical Trials as Topic
  • Colonic Neoplasms (drug therapy)
  • Deoxycytidine (analogs & derivatives, therapeutic use)
  • Female
  • Fluorouracil (analogs & derivatives)
  • Geriatrics
  • Humans
  • Male
  • Medical Oncology
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: